Jobs
-
MannKind Corporation has announced the resignation of Alfred Mann as Executive Chairman and the appointment of Kent Kresa as Chairman of the Board, effective immediately. Mann will continue as a non-executive advisor, the company said.… Read more . . .
-
Serendex Pharmaceuticals has announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved the company’s planned IMPALA Phase 2/3 clinical trial of Molgradex inhaled molgramostim for pulmonary alveolar proteinosis (PAP). According to the… Read more . . .
-
Capsugel and Pulmatrix have announced an agreement for development of new inhaled therapies based on the spray drying and manufacturing expertise at Capsugel’s Bend Research subsidiary combined with Pulmatrix’s iSPERSE dry powder technology. Bend Research… Read more . . .
-
Novel Labs Job Description: Performs laboratory activities including development and validation of chromatographic (HPLC, UPLC, GC) and other applicable analytical methods specific to Metered Dose Inhaler product. Responsibilities: • Conduct reverse engineering, pre-formulation and formulation… Read more . . .
-
Submit workshop proposals by February 26, 2016 at http://www.rddonline.com/rdd/rdd.php?id=13&sid=6&sub=462 For speaker proposals, submit a 200-word summary by March 1, 2016 using the online submission form Read more . . .
-
UK-based Ockham Biotech has announced that data from a Phase 2b study of its inhaled heparin for the treatment of COPD demonstrate significant improvement in lung function compared to placebo, with improvements maintained for 7… Read more . . .
-
Mylan has announced that it will acquire Meda, which markets a number of OINDPs, including Dymista, Astelin, and Astepro nasal sprays; the Aerospan MDI; and the Novopulmon Novolizer and Formatris Novolizer DPIs. Meda had previously… Read more . . .
-
Australian device company Medical Developments International (MVP) has acquired Australian spacer company Breath-A-Tech from Avita Medical for A$2.47 million, comprised of A$2.029 million cash up front and 117,894 shares of MVP stock, which will be… Read more . . .
-
The Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) has acquired Takeda’s Surfactant and Continuous Powder Aerosolization (CPA) program, the company said. According to the announcement, the transfer took place as Takeda shut down its… Read more . . .
-
CDMO Cirrus Pharmaceuticals, a subsidiary of Kemwell, has announced the availability of cGMP inhaler manufacturing services for early phase clinical trials materials at its new facility in Raleigh-Durham, NC. Cirrus announced in October 2014 that… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden